NeoGenomics, Inc. (NEO) Return on equity 2016–2025
NeoGenomics, Inc. (NEO) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-12.9%FY2025 · since FY2016: -3.8% → -12.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -12.9% | -4.2 pp |
| FY2024 | -8.7% | +0.6 pp |
| FY2023 | -9.3% | +5.1 pp |
| FY2022 | -14.5% | -13.7 pp |
| FY2021 | -0.8% | -1.4 pp |
| FY2020 | 0.6% | -1.0 pp |
| FY2019 | 1.6% | +0.8 pp |
| FY2018 | 0.8% | +1.1 pp |
| FY2017 | -0.2% | +3.6 pp |
| FY2016 | -3.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice